{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:17:00Z","timestamp":1740125820419,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s11606-020-06295-y","type":"journal-article","created":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T18:02:43Z","timestamp":1604426563000},"page":"983-987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Implementation and Policy Recommendations from the VHA State-of-the-Art Conference on Strategies to Improve Opioid Safety"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3043-4331","authenticated-orcid":false,"given":"Joseph W.","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy S. B.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Sandbrink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marsden","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"key":"6295_CR1","unstructured":"2019 National Veteran Suicide Prevention Annual Report. Washington, DC: Office of Mental Health and Suicide Prevention, U.S. Department of Veterans Affairs; 2019. https:\/\/www.mentalhealth.va.gov\/docs\/data-sheets\/2019\/2019_National_Veteran_Suicide_Prevention_Annual_Report_508.pdf. Accessed 3 March 2020."},{"issue":"7","key":"6295_CR2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/AJP.0000000000000011","volume":"30","author":"AS Bohnert","year":"2014","unstructured":"Bohnert AS, Ilgen MA, Trafton JA, et al. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain. 2014;30(7):605-612.","journal-title":"Clin J Pain."},{"key":"6295_CR3","unstructured":"Buprenorphine prescribing for opioid use disorder. VHA Notice 2019-18. Washington, DC: Veterans Health Administration, Department of Veterans Affairs; 2019. https:\/\/www.va.gov\/vhapublications\/ViewPublication.asp?pub_ID=8526. Accessed 3 March 2020."},{"key":"6295_CR4","unstructured":"Comprehensive Addiction and Recovery Act of 2016. Public Law No. 114\u2013198; n.d.. https:\/\/www.congress.gov\/114\/plaws\/publ198\/PLAW-114publ198.pdf. Accessed 29 June 2020."},{"issue":"15","key":"6295_CR5","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","volume":"315","author":"D Dowell","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain--United States, 2016. JAMA. 2016;315(15):1624-1645.","journal-title":"JAMA."},{"issue":"24","key":"6295_CR6","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1056\/NEJMp1904190","volume":"380","author":"D Dowell","year":"2019","unstructured":"Dowell D, Haegerich T, Chou R. No shortcuts to safer opioid prescribing. N Engl J Med. 2019;380(24):2285-2287.","journal-title":"N Engl J Med."},{"issue":"3","key":"6295_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.7326\/M17-0598","volume":"167","author":"JW Frank","year":"2017","unstructured":"Frank JW, Lovejoy TI, Becker WC, et al. Patient outcomes in dose reduction or discontinuation of long-term opioid therapy: a systematic review. Ann Intern Med. 2017;167(3):181-191.","journal-title":"Ann Intern Med."},{"issue":"6","key":"6295_CR8","doi-asserted-by":"publisher","first-page":"e196373","DOI":"10.1001\/jamanetworkopen.2019.6373","volume":"2","author":"RL Haffajee","year":"2019","unstructured":"Haffajee RL, Lin LA, Bohnert ASB, Goldstick JE. Characteristics of US counties with high opioid overdose mortality and low capacity to deliver medications for opioid use disorder. JAMA Netw Open. 2019;2(6):e196373.","journal-title":"JAMA Netw Open."},{"key":"6295_CR9","unstructured":"HHS Guide for Clinicians on the Appropriate dosage reduction or discontinuation of long-term opioid analgesics. Washington, DC: U.S. Department of Health and Human Services; 2019. https:\/\/www.hhs.gov\/opioids\/sites\/default\/files\/2019-10\/Dosage_Reduction_Discontinuation.pdf. Accessed 14 Feb 2020."},{"issue":"8","key":"6295_CR10","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/add.13349","volume":"111","author":"MA Ilgen","year":"2016","unstructured":"Ilgen MA, Bohnert AS, Chermack S, et al. A randomized trial of a pain management intervention for adults receiving substance use disorder treatment. Addiction. 2016;111(8):1385-1393.","journal-title":"Addiction."},{"issue":"Suppl 1","key":"6295_CR11","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.2105\/AJPH.2012.300652","volume":"102","author":"J Kemp","year":"2012","unstructured":"Kemp J, Bossarte RM. Surveillance of suicide and suicide attempts among veterans: addressing a national imperative. Am J Public Health. 2012;102 Suppl 1:e4-5.","journal-title":"Am J Public Health."},{"issue":"4","key":"6295_CR12","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s13142-011-0094-3","volume":"1","author":"RD Kerns","year":"2011","unstructured":"Kerns RD, Philip EJ, Lee AW, Rosenberger PH. Implementation of the Veterans Health Administration National Pain Management Strategy. Transl Behav Med. 2011;1(4):635-643.","journal-title":"Transl Behav Med."},{"issue":"Suppl 1","key":"6295_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11606-018-4323-z","volume":"33","author":"B Kligler","year":"2018","unstructured":"Kligler B, Bair MJ, Banerjea R, et al. Clinical policy recommendations from the VHA State-of-the-Art Conference on non-pharmacological approaches to chronic musculoskeletal pain. J Gen Intern Med. 2018;33(Suppl 1):16-23.","journal-title":"J Gen Intern Med."},{"key":"6295_CR14","volume-title":"Evidence brief: Barriers and facilitators to use of medications for opioid use disorder","author":"K Mackey","year":"2019","unstructured":"Mackey K, Veazie S, Anderson J, Bourne D, Peterson K. Evidence brief: Barriers and facilitators to use of medications for opioid use disorder. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs, 2019. VA ESP Project #09-009. https:\/\/www.hsrd.research.va.gov\/publications\/esp\/reports.cfm. Accessed 3 March 2020."},{"key":"6295_CR15","doi-asserted-by":"crossref","unstructured":"Mackey K, Anderson J, Bourne D, Chen E, Peterson K. Evidence brief: Benefits and harms of long-term opioid dose reduction or discontinuation in patients with chronic pain. Washington, DC: Evidence Synthesis Program, Health Services Research and Development Service, Office of Research and Development, Department of Veterans Affairs; 2019. VA ESP Project #09-199. Available at: https:\/\/www.hsrd.research.va.gov\/publications\/esp\/reports.cfm. Accessed 3 Mar 2020.","DOI":"10.1007\/s11606-020-06253-8"},{"issue":"3","key":"6295_CR16","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.jpain.2016.10.021","volume":"18","author":"RL Nahin","year":"2017","unstructured":"Nahin RL. Severe Pain in Veterans: The effect of age and sex, and comparisons with the general population. J Pain. 2017;18(3):247-254.","journal-title":"J Pain."},{"key":"6295_CR17","doi-asserted-by":"publisher","unstructured":"National Academies of Sciences, Engineering, and Medicine. Medications for Opioid Use Disorder Save Lives. Washington, DC: The National Academies Press. 2019. https:\/\/doi.org\/10.17226\/25310. Accessed 14 Feb 2020","DOI":"10.17226\/25310"},{"key":"6295_CR18","unstructured":"National Drug Control Strategy. Washington, DC: Office of National Drug Control Policy; 2019. https:\/\/www.whitehouse.gov\/wp-content\/uploads\/2019\/01\/NDCS-Final.pdf. Accessed 3 March 2020."},{"issue":"4","key":"6295_CR19","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s11606-018-4810-2","volume":"34","author":"AL Nevedal","year":"2019","unstructured":"Nevedal AL, Wagner TH, Ellerbe LS, Asch SM, Koenig CJ. A qualitative study of primary care providers\u2019 experiences with the Veterans Choice Program. J Gen Intern Med. 2019;34(4):598-603.","journal-title":"J Gen Intern Med."},{"key":"6295_CR20","unstructured":"PTSD and suicide: National Center for PTSD Fiscal Year 2018 Annual Report. Washington, DC: National Center for PTSD;2018. https:\/\/www.ptsd.va.gov\/about\/work\/docs\/annual_reports\/2018\/NCPTSD_2018_Annual_Report.pdf. Accessed 3 March 2020."},{"key":"6295_CR21","unstructured":"VA\/DoD clinical practice guideline for opioid therapy for chronic pain. Department of Veterans Affairs and Department of Defense; 2017. https:\/\/www.healthquality.va.gov\/guidelines\/Pain\/cot\/VADoDOTCPG022717.pdf. Accessed 14 Feb 2020."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06295-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06295-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,3]],"date-time":"2021-11-03T00:07:13Z","timestamp":1635898033000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06295-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":21,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6295"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06295-y","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"type":"print","value":"0884-8734"},{"type":"electronic","value":"1525-1497"}],"subject":[],"published":{"date-parts":[[2020,11,3]]},"assertion":[{"value":"10 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}